African Dawn Capital Limited Overview
African Dawn Capital is a micro-cap, AltX-listed South African consumer lender. It is currently suspended from trading and has an equity deficit. Its only operating business is Elite Group (Pty) Ltd, a long-established unsecured micro-lender registered with the National Credit Regulator. Elite lends small, short-tenor personal loans and earns interest, origination, administration and insurance-commission income from a loan book that held R21.0 million gross at February 2024. The group has made a loss every year in the period reviewed. At 31 August 2024 its liabilities exceeded its assets by R63.0 million. It is funded mainly by short-dated, high-cost loans from related parties, Caleo Private Equity vehicles and private lenders. Afdawn has moved between strategies over time: from microfinance, to a diversified niche-finance and property-finance model, to a venture-capital holding company (Knife Capital, 2014–2017), and back to pure microfinance. Its near-term prospects depend on completing its FY2025 audit, lifting the suspension and recapitalising Elite. The proposed EXG Partners transaction is the stated route to that recapitalisation.
Company's own description (paraphrased from the FY2024 Directors' Report)
According to the FY2024 Directors' Report, Afdawn started in 1998 as a microfinance company and grew into a niche finance provider after its 2004 AltX listing. Today it lends unsecured personal loans (micro finance) through its wholly owned subsidiaries Elite Group (Pty) Ltd and Elite Group Two (Pty) Ltd. Profile's Handbook adds that the group offers online consulting to entrepreneurs, investors and advisors through the YueDiligence platform. This description is out of date: the FY2024 AFS record that YueDiligence (Pty) Ltd was sold during FY2024 for R280,000, and the FY2024 subsidiary schedule lists Elite Group Two as dormant.
Independent characterisation
Operating reality: Afdawn is effectively a holding company over one operating lender, Elite Group (Pty) Ltd. The FY2024 AFS list the other subsidiaries (Elite Group Two, African Dawn Debt Management, African Dawn Wheels) as dormant. African Dawn Wheels was deregistered after year end.
Business model: balance-sheet lending. Elite borrows at about 10.5%–18% a year (H1 FY2025 borrowings note) and lends short-term unsecured credit to individuals at much higher effective yields. Elite earns:
-
interest income, recognised under IFRS 9 using the effective interest method;
-
origination (initiation) fees, capitalised into the loan and recognised through the effective interest rate;
-
monthly administration fees on performing loans;
-
commission income from selling third-party credit-life insurance (Elite acts as agent) and from collecting debts for external parties. (FY2024 AFS accounting policy 2.9)
Revenue mix (FY2024): interest income R10.97m (71%); commission, administration and other revenue R4.47m (29%). There is no product sales or subscription revenue. Consulting and advisory revenue appears only in the holding company and is eliminated as intergroup revenue on consolidation.
Value chain position: Elite performs the whole process itself: origination through branches, underwriting, collections and legal recovery. The FY2024 AFS group the loan book into current, collection and legal receivables. Elite outsources insurance underwriting and relies on external funders for capital. FY2024 Key Audit Matters show that an independent expert calculated the IFRS 9 expected credit losses.
Customer types: individuals, mostly employed, lower-to-middle-income South Africans who borrow small amounts. The October 2024 SENS describes Elite's mission as lending to the historically unbanked. The FY2024 AFS also mention "four new clients" signed after year end, which suggests some institutional or employer-channel relationships. These are not described further.
End-markets served: the South African unsecured and short-term consumer credit market regulated under the National Credit Act (NCA). The October 2024 SENS says Elite has offices in Gauteng, North West, Free State and KwaZulu-Natal. The interim segment note says operations are "largely in Gauteng".
Strategy
Stated strategy (paraphrased from the FY2024 AFS and H1 FY2025 board comment)
Grow Elite through external capital: Raise external equity and long-term debt into Elite, mainly via the EXG transaction, and use most of it to expand Elite's loan book. The directors expect this to reverse the loss-making position.
Cover group costs from Elite: Use cash generated by a larger Elite book to pay group operating expenses, including holding-company costs.
Extend and replace short-term funding: Persuade short-term lenders not to recall loans; R17.63m of current borrowings had been approached at the FY2024 sign-off. Find new lenders with longer terms.
Look for other revenue: Explore "other business activities" for additional revenue. None has been named.
Board tone: the H1 FY2025 board comment says management remains positive about the group's core capabilities and intends to grow revenue.
Initiatives in the last 24 months
| Initiative | Date | Description | Status at cut-off |
|---|---|---|---|
| EXG Partners recapitalisation of Elite | Term sheet 30 Sep 2024; SENS 1 Oct 2024 | R5m subscription for 50% of Elite plus R15m long-term loan (repayments starting after 7 years per FY2024 AFS) | Unconfirmed / pending. Circular not found; reclassified as a related-party transaction 24 Jan 2025 |
| Post-year-end funding | FY2024 AFS | R5.9m raised after FY2024 year end, in addition to the R20m EXG package; new lenders advanced R3.8m before the AFS were signed | Completed (amounts as disclosed) |
| TERS refund recovery | FY2024 AFS | R506,851 expected (R211,484 received after year end) | Partially received |
| Loan-term extensions | FY2024 AFS | R17.63m of short-term loans targeted for roll-over | Outcome not disclosed |
| Zero-cost option plan | AGM 29 Sep 2023 | Retention scheme for senior staff | Approved; no awards by Aug 2024 |
| Regulatory remediation with NCR | From Sep 2024 | Submit outstanding statutory returns for Elite Group Two (and possibly Elite) | Outcome not disclosed |
| Audit completion and suspension lift | From Jul 2025 | Complete FY2025 audit with CBS Group; publish interims; apply to lift suspension | Outstanding as of 31 Jul 2026 update |
Medium-term targets / guidance
-
No formal financial guidance has been given.
-
Going-concern projections (FY2024 AFS), conditional on the EXG funding: Elite's net cash received (loan repayments minus new loans) to rise by about R25m over the 12 months from November 2024, and to about R32m over the following 12 months.
Impairment-test assumptions for Elite (FY2024 AFS note 7): compound annual revenue growth 10.6%, long-term loan growth 9.0%, operating cost growth 6.0%, pre-tax WACC 32.88%.
ESG or cost-programme targets: none disclosed.
Products & Services
Afdawn does not publish a product catalogue, pricing schedule or product brand names. The table below covers everything identifiable from the AFS accounting policies and SENS.
Not publicly disclosed: loan sizes, interest-rate caps applied, average tenor, product launch years, customer counts, branch-level product mix, and the identity of the credit-life insurer.
Product Portfolio
| Segment | Offering | Description / capabilities | Target customer | Pricing model (as disclosed) | Status |
|---|---|---|---|---|---|
Micro finance | Unsecured personal loans (Elite brand) | Short-tenor cash loans. Contracts are limited to a maximum of 3–6 months under the revenue policy | Individuals, mainly lower-income, historically under-banked | Interest (effective interest method), capitalised origination fee, fixed monthly administration fee on performing loans | Active |
Micro finance | Credit-life insurance (agency) | Elite sells credit-life cover underwritten by an external insurer and earns commission per premium written | Elite borrowers | Commission, recognised at the point of sale | Active |
Micro finance | Debt collection services | Collection of debts for external parties | External credit providers/clients | Fixed share of amounts collected | Active (scale not disclosed) |
Micro finance | Microfinance software (internal platform) | Internally developed lending software. FY2024 capitalised additions R0.49m; carrying amount R0.69m; useful life 5–10 years | Internal use | Not applicable | Active |
Head office | Consulting and advisory/management fees | Holding-company services to subsidiaries; intergroup revenue only | Group companies | Fees | Intra-group |
Legacy | YueDiligence | Web-based due-diligence platform for entrepreneurs and investors, launched in 2015 | Entrepreneurs, investors, advisors | — | Sold FY2024 (R280k) |
Legacy | Venture capital / fund management (Knife Capital, Grindstone) | VC management and accelerator programme | Tech start-ups, investors | — | Exited 2017–2018 |
Legacy | Bridging, vehicle and structured property finance | Earlier niche-finance lines (property transfer finance via PTF1/PTF2; African Dawn Wheels) | SMEs, property transactions, vehicle buyers | — | Discontinued; entities dormant or diluted |
“—” = not publicly disclosed.
Financial Narrative
Period covered: FY2020–FY2024. FY2025 audited results have not been published (see data status warning), so FY2024 is the latest full year. H1 FY2025 interims are shown separately.
Primary sources: FY2024 audited AFS (covering FY2024 and FY2023); H1 FY2025 unaudited interims; FY2020 summarised results SENS; Profile's Stock Exchange Handbook 2025 Issue 3 (FY2021–FY2022 statistics). Profile's figures are a secondary source and are flagged where used. Blank cells mean the figure was not available in the sources reviewed.
Income statement
Notes: - FY2021–FY2022 operating loss and finance costs are from Profile's Handbook ("Op Inc" and "NetIntPd"). FY2023–FY2024 are from the AFS.
-
FY2021 is marked "restated" by Profile.
-
EBITDA = operating loss + depreciation + amortisation (analyst calculation; it includes right-of-use depreciation).
-
"Net revenue after funding and credit costs" = revenue – finance costs – impairment (analyst calculation). It is used because gross profit is not meaningful for a lender. This calculation matches the FY2024 "revenue" of ~R2.51m shown by StockAnalysis, which explains why that vendor's revenue figure differs from the reported R15.4m.
Margins and growth (%)
FY2020 growth is calculated against FY2019 revenue of R13,335k (FY2020 results SENS). Revenue CAGR: FY2020–FY2024 = 6.4% a year; FY2021–FY2024 = 22.9% a year (analyst calculations).
Commentary — revenue:
-
Revenue fell to R8.3m in FY2021. Profile does not state a cause. Before the Caleo funding arrived, the FY2020 board commentary attributed weak lending to limited new funding while the Sandown debt was being repaid.
-
Caleo's R10m funding and further private borrowing let Elite rebuild its book. Revenue rose 58% in FY2022, 12% in FY2023 and 4.5% in FY2024.
-
Growth then reversed. H1 FY2025 revenue was R6.28m against R7.88m in H1 FY2024 (–20.3%). The gross loan book shrank from R27.4m (Feb 2023) to R21.0m (Feb 2024). Net receivables fell further to R6.8m at Aug 2024.
Commentary — profitability:
-
The operating loss narrowed from R10.0m (FY2021) to R4.5m (FY2024). The main drivers were lower credit impairments (R4.48m to R2.78m) and lower employee costs (R8.43m to R7.24m) in FY2024.
-
These gains were almost fully absorbed by finance costs, which rose from R2.7m (FY2021) to R10.1m (FY2024). In FY2024 finance costs nearly equalled interest income (R10.97m).
The structural problem is visible here: The group funds a small loan book with expensive, largely short-term debt. The interest spread is too thin to cover operating costs once credit losses and fees are included.
Balance sheet
Sources: - FY2023–FY2024 from the AFS.
-
FY2020 total liabilities and equity from the FY2020 results SENS. FY2020 cash is derived from the reported opening cash and net cash movement.
-
FY2021–FY2022 from Profile's Handbook (equity, long-term and current liabilities, current assets). Total assets and total liabilities for those years are analyst derivations (equity + liabilities).
-
FY2022 cash is the FY2023 opening cash in the AFS cash-flow statement.
H1 FY2025 (31 Aug 2024, unaudited):
-
Total assets R10.54m; cash R0.46m; net receivables R6.83m.
-
Total borrowings R63.87m (R32.79m current; R31.08m non-current); leases R1.67m.
-
Total liabilities R73.56m; equity –R63.01m.
-
Current assets R7.70m against current liabilities R41.62m (current ratio 0.19).
Commentary — balance sheet:
Equity: The equity deficit widened every year, from –R2.9m (Feb 2020) to –R63.0m (Aug 2024). Accumulated losses of R392.2m now exceed paid-in share capital and premium of R329.2m.
Funding: Borrowings grew 18% in FY2024 and a further 9.5% in the six months to Aug 2024. The loan book they fund shrank over the same periods.
Credit quality: The ECL allowance covered 65.8% of the gross book at Feb 2023 and 59.7% at Feb 2024. This implies that a large share of the book is non-performing (Stage 3, legal) exposure.
Encumbrance: R19.26m of trade receivables (carrying amount, Feb 2024) were ceded as security to lenders. Almost the entire book is pledged.
Cash flow
Sources: FY2024 AFS (FY2023–FY2024); FY2020 results SENS (net cash movement). FCF = operating cash flow – capex (analyst calculation). Dividends and buybacks: the FY2024 AFS state that no dividend was declared or paid in FY2024 or FY2023. No buybacks were identified in any year. FY2020–FY2022 zeros reflect the absence of any dividend disclosure in the sources reviewed.
H1 FY2025: operating cash outflow R5.53m; investing inflow R0.41m; financing inflow R4.84m (R8.79m new borrowings less R3.45m repayments); net cash change –R0.27m.
Commentary — cash flow: Free cash flow has been negative by about R10–11m a year. New borrowing has filled the gap almost entirely, with small equity placements at 40c topping it up. Cash interest paid (R7.25m in FY2024) is below the finance-cost charge (R10.14m). The difference is accrued interest and consulting fees, such as the R2.32m owed to Caleo at Aug 2024 and included in trade payables. Unpaid finance charges are therefore building up on the balance sheet.
Ratios
Notes: Not meaningful: ROE (negative equity), ROIC, net debt/EBITDA (negative EBITDA) and the cash conversion cycle (lender with no inventory or payables cycle). These are left blank.
-
Implied cost of borrowings = FY2024 finance costs ÷ average borrowings (R53.8m). It includes lease interest and consulting fees.
-
Interest yield = FY2024 interest income ÷ average gross receivables (R24.2m).
-
All ratios are analyst calculations from AFS and Profile data.
Inflections and drivers (summary):
-
FY2021 trough: a funding squeeze collapsed revenue to R8.3m.
-
FY2022–FY2023 rebuild: a debt-funded rebuild restored revenue, but credit impairments (R4.5m in FY2023) and rising finance costs widened the net loss to R16.2m.
-
FY2024: operating improvement (operating loss –44%) was offset by finance costs (+29%).
-
H1 FY2025: the loan book began to run off, revenue fell 20%, and the loss widened to R8.8m for six months, an annualised pace above FY2024.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Revenue (ZAR K) | 12,035 | 8,324 | 13,168 | 14,764 | 15,435 |
Interest income (ZAR K) | — | — | — | 10,940 | 10,970 |
Commission administration and other revenue (ZAR K) | — | — | — | 3,824 | 4,465 |
Credit impairment charge (ZAR K) | — | — | — | -4,477 | -2,780 |
Finance costs (ZAR K) | — | -2,686 | -5,539 | -7,862 | -10,143 |
Net revenue after funding and credit costs (ZAR K) | — | — | — | 2,425 | 2,512 |
Employee benefits expense (ZAR K) | — | — | — | -8,429 | -7,240 |
Other operating expenses (ZAR K) | — | — | — | -9,105 | -9,417 |
Depreciation and amortisation (ZAR K) | — | — | — | -765 | -994 |
Operating profit/loss (ZAR K) | — | -10,004 | -7,257 | -7,937 | -4,483 |
EBITDA approx (ZAR K) | — | — | — | -7,172 | -3,489 |
Pre-tax loss (ZAR K) | -10,345 | — | — | -15,799 | -14,626 |
Income tax (ZAR K) | — | — | — | -353 | 0 |
Net loss attributable (ZAR K) | -10,345 | -12,751 | -12,894 | -16,152 | -14,626 |
Basic and diluted EPS (ZAc) | — | — | — | -24.5 | -20.3 |
Headline EPS (ZAc) | — | -23.1 | -20.3 | -24.5 | -20.3 |
Dividend per share (ZAc) | — | — | — | 0 | 0 |
Margin Analysis (%)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | -9.7 | -30.8 | 58.2 | 12.1 | 4.5 |
Net revenue margin after funding and credit costs (%) | — | — | — | 16.4 | 16.3 |
Operating margin (%) | — | -120.2 | -55.1 | -53.8 | -29.0 |
EBITDA margin (%) | — | — | — | -48.6 | -22.6 |
Net margin (%) | -86.0 | -153.2 | -97.9 | -109.4 | -94.8 |
Finance costs as % of revenue (%) | — | 32.3 | 42.1 | 53.3 | 65.7 |
Cost-to-income ratio incl D&A (%) | — | — | — | 123.9 | 114.4 |
Credit impairment as % of interest income (%) | — | — | — | 40.9 | 25.3 |
Balance Sheet
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Total assets (ZAR K) | 11,982 | 10,987 | 16,103 | 14,550 | 13,604 |
Cash and equivalents (ZAR K) | 411 | — | 1,375 | 1,106 | 730 |
Gross trade receivables (ZAR K) | — | — | — | 27,422 | 21,025 |
ECL loss allowance (ZAR K) | — | — | — | 18,047 | 12,545 |
Net trade and other receivables (ZAR K) | — | — | — | 9,610 | 8,672 |
Current assets (ZAR K) | — | 9,229 | 14,701 | 12,382 | 10,235 |
Goodwill and intangibles (ZAR K) | — | — | — | 817 | 1,188 |
Borrowings short-term (ZAR K) | — | — | — | 30,874 | 33,511 |
Borrowings long-term (ZAR K) | — | — | — | 18,465 | 24,841 |
Total borrowings (ZAR K) | — | — | — | 49,339 | 58,352 |
Lease liabilities (ZAR K) | — | — | — | 1,196 | 2,068 |
Net debt incl leases (ZAR K) | — | — | — | 49,429 | 59,690 |
Total liabilities (ZAR K) | 14,884 | 24,858 | 42,868 | 55,558 | 67,838 |
Current liabilities (ZAR K) | — | 8,917 | 11,332 | 36,509 | 41,753 |
Total equity (ZAR K) | -2,902 | -13,871 | -26,765 | -41,008 | -54,234 |
Working capital (ZAR K) | — | 312 | 3,369 | -24,127 | -31,518 |
Net asset value per share (ZAc) | — | -21.79 | -42.05 | -58.57 | -73.78 |
Cash Flow
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Cash used in operations before interest and tax (ZAR K) | — | — | — | -3,247 | -1,979 |
Interest paid (ZAR K) | — | — | — | -7,706 | -7,250 |
Operating cash flow (ZAR K) | — | — | — | -11,004 | -9,388 |
Capex PPE plus intangibles (ZAR K) | — | — | — | 116 | 507 |
Free cash flow (ZAR K) | — | — | — | -11,120 | -9,895 |
Net new borrowings (ZAR K) | — | — | — | 11,348 | 8,623 |
Share issue proceeds (ZAR K) | — | — | — | 1,909 | 1,400 |
Dividends paid (ZAR K) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (ZAR K) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (ZAR K) | -1,977 | — | — | -269 | -376 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
ROA on average assets (%) | -111.0 | -95.2 | -105.4 | -103.9 |
Current ratio (x) | 1.03 | 1.30 | 0.34 | 0.25 |
Debt to equity per Profile (x) | -1.55 | -1.47 | -1.23 | -1.10 |
Interest coverage EBIT over finance costs (x) | -3.72 | -1.31 | -1.01 | -0.44 |
Asset turnover (x) | 0.72 | 0.97 | 0.96 | 1.10 |
Implied cost of borrowings (%) | — | — | — | 18.8 |
Interest yield on average gross book (%) | — | — | — | 45.3 |
Revenue by Region and Revenue by Region (%)
| Region | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
South Africa revenue (ZAR K) | 13,168 | 14,764 | 15,435 |
Rest of world revenue (ZAR K) | 0 | 0 | 0 |
South Africa share of revenue (%) | 100 | 100 | 100 |
South Africa revenue growth (%) | 58.2 | 12.1 | 4.5 |
Capital Markets
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Share price high (ZAc) | 29 | 40 | 35 | 22 |
Share price low (ZAc) | 5 | 6 | 4 | 5 |
Share price period end (ZAc) | 10 | 23 | 13 | 9 |
Share Price & Returns
| Period | Reference start | Return to 13c |
|---|---|---|
From FY2024 year end (Feb 2024, 9c) | 9c | +44% |
From FY2023 year end (Feb 2023, 13c) | 13c | 0% |
From FY2022 year end (Feb 2022, 23c) | 23c | -43% |
From FY2021 year end (Feb 2021, 10c) | 10c | +30% |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalisation | R9.56m | 73.51m shares × 13c |
P/B | -0.15x | Negative NAV of –R63.0m (Aug 2024) |
Enterprise value | ~R74.6m | Market cap + borrowings R63.87m + leases R1.67m – cash R0.46m (Aug 2024) |
EV/Sales (TTM to Aug 2024) | ~5.4x | TTM revenue ≈ R13.8m (FY2024 R15.44m – H1 FY2024 R7.88m + H1 FY2025 R6.28m) |
Capital Markets — Analyst consensus
| Item | Status |
|---|---|
Analyst consensus | None. Zero covering analysts (Simply Wall St) |
Dividend history / policy | No dividends in FY2023 or FY2024 (FY2024 AFS); none identified in the period reviewed. No stated policy |
Buyback authorisation | General authority to acquire own shares passed as a special resolution at the 29 Sep 2023 AGM; no repurchases disclosed |
Equity issuance | Private placements at 40c: 1.5m shares (17 May 2023) and 2.0m shares (30 Aug 2023); 2019 placements at 35c and 40c |
Credit ratings (Moody's / S&P / Fitch) | None; not rated |
Debt Facilities
| Facility | Amount (ZAR K) | Rate | Security | Maturity |
|---|---|---|---|---|
Caleo Private Equity (net of fees) | 8,268 | 15.6% + 2.4% consulting | Unsecured | 20 years from 2021, repayable at the group's discretion (early-termination penalty) |
Related parties: unsecured, 12 months | 2,065 | 18% | Unsecured | Within 12 months |
Related parties: unsecured, on demand | 4,867 | 10.5%–18% | Unsecured | On demand |
Related parties: unsecured, long-term | 807 | 18% | Unsecured | 36 months |
Caleo loan programme | 13,480 | 15% | Ceded receivables at 1.2× | Within 3 months |
Unrelated: unsecured, long-term | 10,200 | 15%–18% | Unsecured | 24–36 months |
Unrelated: unsecured, short-term | 23,082 | 10.5%–18% | Unsecured | Within 12 months |
Unrelated: secured single-cover, short-term | 1,100 | 17% | Receivables | Within 12 months |
Total borrowings | 63869 | — | — | Current 32,789 / Non-current 31,080 |
Analyst Conclusions
Management guidance and consensus
- These projections date from September 2024 and assumed the transaction would complete. That has not been confirmed.
Consensus: none (no analyst coverage).
Bull case
-
Recapitalisation works. If the EXG transaction closes (R5m equity + R15m 7-year-grace loan), Elite's funding would roughly match its FY2024 gross book of R21.0m. That could double lending capacity and replace part of the 15–18% short-term debt.
-
Operating leverage exists. FY2024 operating losses had already fallen to R4.5m from R10.0m in FY2021, and FY2024 net revenue after funding and credit costs was R2.5m. Cheaper funding plus a larger book could plausibly bring operating breakeven.
-
Insiders have strong incentives. Directors own about 39% and, with related parties, fund much of the debt. They have strong reasons to finish the audit and restore the listing, which would allow equity placements again.
Bear case
-
Insolvency on a balance-sheet basis. Liabilities exceed assets by R63.0m (Aug 2024), and the deficit has grown by R10–16m a year. Even R20m of new EXG money would not restore positive equity at group level.
-
Interest consumes the economics. Finance costs (R10.1m) were 92% of interest income in FY2024, and the loan book shrank 23% in FY2024 and further in H1 FY2025.
-
Governance and reporting failures may be terminal for the listing. The group faces a second suspension in two years, the previous auditor resigned after a risk assessment, the FY2025 AFS remain unpublished more than 19 months after year end, interims are missed, and an NCR notice is outstanding. Removal from the JSE is a realistic outcome. The related-party EXG deal would also give away 50% of the only operating asset for R5m.
Catalysts and monitorables (next 12 months)
-
Publication of FY2025 audited AFS: the audit opinion type (modified or unmodified), going-concern wording, and any restatements.
-
Publication of the overdue interims (six months to Aug 2025) and the FY2026 AFS (year ended 28 Feb 2026, also due).
-
Next quarterly suspension update (late October 2026) and any JSE decision on removal.
-
EXG circular, independent fairness opinion, and the shareholder vote (related-party votes excluded).
-
NCR registration status of Elite and Elite Group Two.
-
Trend in borrowings, and whether short-term lenders recall loans.
-
Any board changes to address King IV independence requirements.
Analyst verdict
African Dawn Capital is a listed shell around one small, undercapitalised micro-lender. Its main risk is not commercial. It is a combined solvency, governance and reporting risk. On the last published figures (31 August 2024) the group had R10.5 million of assets against R73.6 million of liabilities. Nearly all of those liabilities are interest-bearing loans at 10.5%–18%, about half of them due within a year, and many from directors, their relatives or affiliated vehicles. The lending business generates real revenue (R15.4 million in FY2024) and has shown some operational discipline: credit impairments and staff costs both fell in FY2024. But the cost of funding absorbs almost all of the interest income, and the book has been shrinking since FY2024.
The proposed EXG transaction is the only disclosed route to recapitalisation. It is small relative to the deficit. It is now a related-party transaction. And it gives up half of Elite for R5 million of equity. Even if it completes, minority shareholders in the listed company would hold a 50% stake in a subsidiary with deeply negative net assets.
Separately, the group has not published audited accounts for a year that ended in February 2025. Its previous auditor resigned after a risk assessment, and its own deadlines have slipped six times since June 2025. Until audited FY2025 and FY2026 figures are published, the current financial position cannot be verified. Any valuation, including the stale 13c last trade (R9.6 million market capitalisation, ~R75 million enterprise value), has little evidential support.
Overall assessment: very high risk, with a binary outcome. Re-listing would require publishing the outstanding financial statements, completing a fair recapitalisation, and repairing NCR compliance and board independence. Without all three, removal from the JSE or a restructuring that dilutes minority shareholders appears more likely than recovery. This is an analytical judgement based on public filings, not investment advice.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Designation | Tenure / background (as disclosed) | Qualification |
|---|---|---|---|---|
James (J) Slabbert | Executive Chairman and (Interim) CEO | Executive | Board member before FY2023; holds his shares indirectly via Arvesco 153 (Pty) Ltd. Age, education and start date not disclosed in the documents reviewed | — |
Graham B Hope | Chief Financial Officer | Executive | CFO/executive director since 11 Jan 2016 (MarketScreener); previously finance director at Elite Group | CA(SA) |
B Stagman | Chair, Audit & Risk Committee and Remuneration Committee | Independent non-executive | Lead independent NED | CA(SA) |
S Blieden | Chair, Social & Ethics Committee | Non-executive (not independent) | Shareholding held indirectly via Caleo Afdawn LLP; lender to the group (R1.8m loan) | CFA |
“—” = not publicly disclosed.
Directors' Remuneration
| Metric | FY2024 | H1FY2025 |
|---|---|---|
Employee cost paid to key management incl directors (ZAR K) | 2,148 | 1,074 |
Non-executive director fees owing at period end (ZAR K) | 742 | 837 |
Major Shareholders
| Holder | Stake (%) | Date | Notes |
|---|---|---|---|
Arvesco 153 (Pty) Ltd | 36.46 | 29 Feb 2024 | Vehicle of CEO/Chair J Slabbert |
Caleo Afdawn Limited Liability Partnership | 17.32 | 29 Feb 2024 | Caleo vehicle; S Blieden holds an indirect interest |
Independent Municipal and Allied Trade Union (IMATU) | 6.48 | 29 Feb 2024 | Trade union investor |
Other holders | 39.74 | 29 Feb 2024 | Below 5%; not individually disclosed in sources reviewed |
Competitive Landscape
Key Competitors
| Competitor | Type | Overlap with Elite | Comparative data (verified) |
|---|---|---|---|
Finbond Group Ltd (JSE: FGL) | Listed micro-lender (South Africa and North America) | Direct: short-term unsecured loans via branches | FY2025: revenue R1,699m; attributable profit R31.8m; total assets R4.53bn; gross loans R1.11bn |
Capitec Bank Holdings | Retail bank | Unsecured personal loans to mass market | — |
African Bank | Retail bank | Unsecured personal loans | — |
Old Mutual Finance | Insurer-owned lender | Unsecured personal loans | — |
Bayport Financial Services | Payroll-deduction lender | Employed borrowers | — |
Lesaka Technologies (Moneyline / consumer lending) | Fintech / lender | Lower-income borrowers | — |
TymeBank | Digital bank | Unbanked and under-banked customers | — |
Wonga SA and other online short-term lenders | Digital short-term credit | Small, short-tenor loans | — |
Real People | Specialist lender | Lower-income credit | — |
Independent NCR-registered micro-lenders | Local branch lenders | Direct, same geography and customer type | Fragmented; not quantifiable |
Peer Comparison FY2025
| Metric | Afdawn (FY2024) | Finbond (FY2025) |
|---|---|---|
Revenue | R15.4m | R1,699m |
Revenue growth | 4.5% | 7.9% |
Net profit/(loss) | (R14.6m) | R31.8m attributable |
Net margin | -94.8% | ~1.9% (analyst calc.) |
Total assets | R13.6m | R4.53bn |
R&D intensity | 3.2% (capitalised software) | — |
“—” = not publicly disclosed.
Recent Developments
Afdawn's disclosure in the last 18 months consists almost entirely of reporting delays and suspension updates. Entries 1–9 are earlier context, included because they directly explain the current position.
*Unresolved items with no update found: the outcome of the EXG transaction; the outcome of the NCR notice; FY2026 (year ended 28 Feb 2026) reporting, which is also due.
*Aggregator artefacts: StockAnalysis shows an "earnings date" of 31 Jul 2026, and Simply Wall St refers to "nine months 2026 results" on 31 Aug 2026. Afdawn does not report nine-month results. These appear to be vendor calendar estimates and were not confirmed by any primary filing.



